Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Premier Pharmacy Labs Inc
483
•Premier Pharmacy Labs Inc•June 13, 2016

Premier Pharmacy Labs Inc – FDA 483, Jun 13, 2016

Record Details

This FDA Form 483 details 20 observations from an inspection of an outsourcing facility.

**Facility and Operations:** The facility compounds various ophthalmic and injectable drug products.

**Violations and Observations:**

* **Aseptic Processing & Environmental Control:** * Deficient air supply in aseptic processing areas (HEPA filtered, positive pressure). * Lack of procedures for HEPA filter certification and airflow pattern studies (smoke studies) for ISO 5 areas. * Inadequate smoke studies showing non-unidirectional/turbulent air in ISO 5 laminar airflow working hood (LAFW), impacting multiple batches. * LAFW located in a cleanroom not suitable to prevent cross-contamination from personnel movement. * Environmental Monitoring (EMI) excursion investigations (fingertips) were incomplete, lacked timely CAPA, microorganism identification, and trend evaluation. * **Quality Control & Testing:** * Inadequate acceptance criteria for visual inspection of sterile products; 100% inspection not required, no defect criteria, and incomplete documentation of defects in batch records. * No retesting or re-examination of sterile plastic vials (droppers) after storage, lacking data to ensure sterility of re-sealed, opened vials. * **Equipment & Maintenance:** * Equipment not properly qualified during installation or maintained at appropriate intervals. * Failed media fill

Company
Premier Pharmacy Labs Inc
Inspection date
June 13, 2016
Product type
Drugs
Office
Florida District Office
People
  • Noreen Muniz (Investigator)
  • Leana Barreto-Pettit (Vice President, Technical)
View Company Profile

ID · a5844294-7a9c-4e4b-9a2b-bf67907c4561

Violation Codes10
21 U.S.C. 351(d)21 U.S.C. 353b(a)(11)21 U.S.C. 331(c)21 U.S.C. 351(c)21 U.S.C. 351(b)21 CFR 211FD&C Act 801(a)(3)21 CFR 211.165(e)21 CFR 211.198(a)21 CFR 211.180(e)

Full citation text and observation details available on the Dashboard.

Other documents for Premier Pharmacy Labs Inc
  • 483 - 2019-06-12June 12, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Premier Pharmacy Labs Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.